4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Abeona Therapeutics Inc. (ABEO) operates in the Biotechnology industry and is headquartered in Cleveland, United States with about 226 employees. Its market capitalization is roughly $345 million. In the fiscal year ended 2025-12-31, ABEO reported $6M in revenue and $71M in net income.
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.
Interactive charts & full statements → Open the ABEO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $6M | $0M | $4M | $1M | — |
| Gross Profit | $2M | $0M | $2M | $1M | — |
| Operating Income (EBIT) | ($89M) | ($64M) | ($48M) | ($45M) | — |
| Net Income | $71M | ($64M) | ($54M) | ($40M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $9M | $5M | $0M | $0M | $0M | — |
| Gross Profit | $6M | $3M | ($0M) | $0M | $0M | — |
| Operating Income (EBIT) | ($23M) | ($23M) | ($24M) | ($23M) | ($20M) | — |
| Net Income | ($17M) | ($20M) | ($5M) | $109M | ($12M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $220M | $109M | $64M | $64M | — |
| Total Liabilities | $60M | $65M | $49M | $38M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABEO viewer.
About TickerBase · Data methodology & sources